Incidence, prescription patterns, and determinants of antipsychotic use in patients with Parkinson's disease
Identifieur interne : 000288 ( Main/Exploration ); précédent : 000287; suivant : 000289Incidence, prescription patterns, and determinants of antipsychotic use in patients with Parkinson's disease
Auteurs : Meng-Ting Wang [République populaire de Chine] ; Pei-Wen Lian [République populaire de Chine] ; Chin-Bin Yeh [République populaire de Chine] ; Che-Hung Yen [République populaire de Chine] ; Kao-Hsing Ma [République populaire de Chine] ; Agnes L. F. Chan [République populaire de Chine]Source :
- Movement Disorders [ 0885-3185 ] ; 2011-08-01.
English descriptors
Abstract
Empirical data regarding the choice of antipsychotics for the management of psychosis in patients with Parkinson's disease are limited. This study aimed to evaluate the incidence and prescribing patterns of antipsychotics and to determine the predictors associated with the prescribing of typical antipsychotics in patients with Parkinson's disease. This was a retrospective cohort study analyzing data from the National Health Insurance Research Database in Taiwan between January 1, 2000, and December 31, 2006, in which patients with Parkinson's disease (ICD‐9‐CM codes 332) initially receiving any antiparkinsonian drug (n = 2095) were followed up to evaluate the subsequent use of antipsychotics. Kaplan–Meier statistics and multiple logistic regression were employed to evaluate the cumulative probability of antipsychotic use and determinants of prescribing of typical antipsychotics, respectively. The cumulative probability of initiation of an antipsychotic within 6 years was found to be 51%, and the proportion of patients who began taking an atypical antipsychotic increased from 11.1% in 2001 to 36.1% in 2005. Physician specialty was found to be the most influential predictor of the prescribing of typical antipsychotics: physicians with an internal medicine specialty were 10.62 times more likely (95% confidence interval, 4.64–24.32) to prescribe typical antipsychotics than were neurologists. The use of antipsychotics in Parkinson's disease is common, and the use of typical antipsychotics dominates antipsychotic treatment. Particular attention needs to be paid to improving practice, including efforts that encourage primary care providers to have the appropriate choice of antipsychotics in patients with Parkinson's disease. © 2011 Movement Disorder Society
Url:
DOI: 10.1002/mds.23719
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Incidence, prescription patterns, and determinants of antipsychotic use in patients with Parkinson's disease</title><author><name sortKey="Wang, Meng Ing" sort="Wang, Meng Ing" uniqKey="Wang M" first="Meng-Ting" last="Wang">Meng-Ting Wang</name></author><author><name sortKey="Lian, Pei En" sort="Lian, Pei En" uniqKey="Lian P" first="Pei-Wen" last="Lian">Pei-Wen Lian</name></author><author><name sortKey="Yeh, Chin In" sort="Yeh, Chin In" uniqKey="Yeh C" first="Chin-Bin" last="Yeh">Chin-Bin Yeh</name></author><author><name sortKey="Yen, Che Ung" sort="Yen, Che Ung" uniqKey="Yen C" first="Che-Hung" last="Yen">Che-Hung Yen</name></author><author><name sortKey="Ma, Kao Sing" sort="Ma, Kao Sing" uniqKey="Ma K" first="Kao-Hsing" last="Ma">Kao-Hsing Ma</name></author><author><name sortKey="Chan, Agnes L F" sort="Chan, Agnes L F" uniqKey="Chan A" first="Agnes L. F." last="Chan">Agnes L. F. Chan</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6186EB55C15529CAC977E752EE2F530A35C0AF24</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1002/mds.23719</idno><idno type="url">https://api.istex.fr/document/6186EB55C15529CAC977E752EE2F530A35C0AF24/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000800</idno><idno type="wicri:Area/Main/Curation">000697</idno><idno type="wicri:Area/Main/Exploration">000288</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Incidence, prescription patterns, and determinants of antipsychotic use in patients with Parkinson's disease</title><author><name sortKey="Wang, Meng Ing" sort="Wang, Meng Ing" uniqKey="Wang M" first="Meng-Ting" last="Wang">Meng-Ting Wang</name><affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>School of Pharmacy, National Defense Medical Center, Taipei, Taiwan</wicri:regionArea><wicri:noRegion>Taiwan</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Meng‐Ting Wang, 9 F, No. 161, Section 6, Min‐Chuan East Road, Taipei 114, Taiwan, Republic of ChinaAgnes L.F. Chan, 901, Chung‐Hwa Road, Young Kang City, Tainan 710, Taiwan</wicri:regionArea><wicri:noRegion>Taiwan</wicri:noRegion></affiliation></author><author><name sortKey="Lian, Pei En" sort="Lian, Pei En" uniqKey="Lian P" first="Pei-Wen" last="Lian">Pei-Wen Lian</name><affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>School of Pharmacy, National Defense Medical Center, Taipei, Taiwan</wicri:regionArea><wicri:noRegion>Taiwan</wicri:noRegion></affiliation></author><author><name sortKey="Yeh, Chin In" sort="Yeh, Chin In" uniqKey="Yeh C" first="Chin-Bin" last="Yeh">Chin-Bin Yeh</name><affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Psychiatry, Tri‐Service General Hospital, Taipei, Taiwan</wicri:regionArea><wicri:noRegion>Taiwan</wicri:noRegion></affiliation></author><author><name sortKey="Yen, Che Ung" sort="Yen, Che Ung" uniqKey="Yen C" first="Che-Hung" last="Yen">Che-Hung Yen</name><affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Neurology, Tri‐Service General Hospital, Taipei, Taiwan</wicri:regionArea><wicri:noRegion>Taiwan</wicri:noRegion></affiliation></author><author><name sortKey="Ma, Kao Sing" sort="Ma, Kao Sing" uniqKey="Ma K" first="Kao-Hsing" last="Ma">Kao-Hsing Ma</name><affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Biology and Anatomy, School of Medicine, National Defense Medical Center, Taipei, Taiwan</wicri:regionArea><wicri:noRegion>Taiwan</wicri:noRegion></affiliation></author><author><name sortKey="Chan, Agnes L F" sort="Chan, Agnes L F" uniqKey="Chan A" first="Agnes L. F." last="Chan">Agnes L. F. Chan</name><affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Pharmacy, Chi Mei Medical Center, Tainan, Taiwan</wicri:regionArea><wicri:noRegion>Taiwan</wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Meng‐Ting Wang, 9 F, No. 161, Section 6, Min‐Chuan East Road, Taipei 114, Taiwan, Republic of ChinaAgnes L.F. Chan, 901, Chung‐Hwa Road, Young Kang City, Tainan 710, Taiwan</wicri:regionArea><wicri:noRegion>Taiwan</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-08-01">2011-08-01</date><biblScope unit="volume">26</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="1663">1663</biblScope><biblScope unit="page" to="1669">1669</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">6186EB55C15529CAC977E752EE2F530A35C0AF24</idno><idno type="DOI">10.1002/mds.23719</idno><idno type="ArticleID">MDS23719</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>antipsychotics</term><term>prescription patterns</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Empirical data regarding the choice of antipsychotics for the management of psychosis in patients with Parkinson's disease are limited. This study aimed to evaluate the incidence and prescribing patterns of antipsychotics and to determine the predictors associated with the prescribing of typical antipsychotics in patients with Parkinson's disease. This was a retrospective cohort study analyzing data from the National Health Insurance Research Database in Taiwan between January 1, 2000, and December 31, 2006, in which patients with Parkinson's disease (ICD‐9‐CM codes 332) initially receiving any antiparkinsonian drug (n = 2095) were followed up to evaluate the subsequent use of antipsychotics. Kaplan–Meier statistics and multiple logistic regression were employed to evaluate the cumulative probability of antipsychotic use and determinants of prescribing of typical antipsychotics, respectively. The cumulative probability of initiation of an antipsychotic within 6 years was found to be 51%, and the proportion of patients who began taking an atypical antipsychotic increased from 11.1% in 2001 to 36.1% in 2005. Physician specialty was found to be the most influential predictor of the prescribing of typical antipsychotics: physicians with an internal medicine specialty were 10.62 times more likely (95% confidence interval, 4.64–24.32) to prescribe typical antipsychotics than were neurologists. The use of antipsychotics in Parkinson's disease is common, and the use of typical antipsychotics dominates antipsychotic treatment. Particular attention needs to be paid to improving practice, including efforts that encourage primary care providers to have the appropriate choice of antipsychotics in patients with Parkinson's disease. © 2011 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>République populaire de Chine</li></country></list><tree><country name="République populaire de Chine"><noRegion><name sortKey="Wang, Meng Ing" sort="Wang, Meng Ing" uniqKey="Wang M" first="Meng-Ting" last="Wang">Meng-Ting Wang</name></noRegion><name sortKey="Chan, Agnes L F" sort="Chan, Agnes L F" uniqKey="Chan A" first="Agnes L. F." last="Chan">Agnes L. F. Chan</name><name sortKey="Chan, Agnes L F" sort="Chan, Agnes L F" uniqKey="Chan A" first="Agnes L. F." last="Chan">Agnes L. F. Chan</name><name sortKey="Lian, Pei En" sort="Lian, Pei En" uniqKey="Lian P" first="Pei-Wen" last="Lian">Pei-Wen Lian</name><name sortKey="Ma, Kao Sing" sort="Ma, Kao Sing" uniqKey="Ma K" first="Kao-Hsing" last="Ma">Kao-Hsing Ma</name><name sortKey="Wang, Meng Ing" sort="Wang, Meng Ing" uniqKey="Wang M" first="Meng-Ting" last="Wang">Meng-Ting Wang</name><name sortKey="Yeh, Chin In" sort="Yeh, Chin In" uniqKey="Yeh C" first="Chin-Bin" last="Yeh">Chin-Bin Yeh</name><name sortKey="Yen, Che Ung" sort="Yen, Che Ung" uniqKey="Yen C" first="Che-Hung" last="Yen">Che-Hung Yen</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000288 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000288 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:6186EB55C15529CAC977E752EE2F530A35C0AF24
|texte= Incidence, prescription patterns, and determinants of antipsychotic use in patients with Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |